Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

New York Times - Sep 30, 2026

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

Read full article

More News

Still Surge

Let your "surge" of emotions burst forth when reading the news articles acknowledging the beauty and vastness of Science and futuristic Technologies.

NEWSLETTER